Ligand validation:3VVK

BNG: nonyl beta-D-glucopyranoside

BNG is a Ligand Of Interest in 3VVK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VVK_BNG_A_303	19%	40%	0.262	0.858	1.62	0.8	6	1	0	0	100%	1
3VVK_BNG_B_302	19%	42%	0.259	0.851	1.6	0.72	6	-	2	0	100%	1
3VVK_BNG_A_302	16%	39%	0.252	0.818	1.76	0.71	6	-	2	0	100%	1
3VVK_BNG_D_304	14%	38%	0.208	0.756	1.75	0.78	7	-	0	0	100%	1
5B0W_BNG_F_304	71%	49%	0.114	0.934	1.25	0.73	3	-	2	0	100%	1
5ETZ_BNG_B_304	58%	42%	0.143	0.921	1.6	0.7	6	-	1	0	100%	1
4QRY_BNG_E_301	43%	41%	0.171	0.894	1.69	0.7	6	-	4	0	100%	1
3QBI_BNG_B_402	24%	41%	0.216	0.843	1.68	0.7	6	-	0	0	100%	1
3QBG_BNG_B_402	17%	41%	0.295	0.876	1.65	0.71	6	-	0	0	100%	1
4RP9_BNG_A_503	84%	70%	0.091	0.952	0.38	0.76	-	-	3	0	100%	1
4MES_BNG_B_201	72%	51%	0.128	0.953	0.83	1.05	-	2	5	0	100%	1
4MUU_BNG_A_202	70%	42%	0.117	0.934	0.85	1.45	-	6	1	0	100%	0.66
4HHR_BNG_A_714	67%	19%	0.098	0.907	0.83	2.76	2	9	1	0	100%	0.381
6F7H_BNG_A_401	65%	46%	0.132	0.933	0.76	1.35	-	5	2	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.